fludarabine has been researched along with Leukemia, Lymphoid in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.11) | 18.7374 |
| 1990's | 2 (11.11) | 18.2507 |
| 2000's | 7 (38.89) | 29.6817 |
| 2010's | 7 (38.89) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Appelhans, D; Borowiec, M; Bryszewska, M; Franiak-Pietryga, I; Jander, M; Maciejewski, H; Ostrowska, K; Treliński, J; Voit, B; Ziemba, B | 1 |
| Haeusler, GM; Lingaratnam, S; Seymour, JF; Slavin, MA; Tam, CS; Teh, BW; Thursky, KA; Worth, LJ | 1 |
| Aloyz, R; Assouline, SE; Autexier, C; Chu, TW; Gryaznov, SM; Johnston, JB; Lees-Miller, SP; Martinez-Marignac, V; Shawi, M; Yu, Y | 1 |
| Carney, D; Gill, S; Januszewicz, H; Prince, HM; Ritchie, D; Seymour, JF; Westerman, D; Wolf, M | 1 |
| Bojarska-Junak, A; Chocholska, S; Dmoszynska, A; Klimek, P; Kowal, M; Podhorecka, M | 1 |
| Brewer, SC; Cleveland, KO; Gelfand, MS | 1 |
| Anasetti, C; Ayala, E; Fernandez, HF; Field, T; Kharfan-Dabaja, MA; Kim, J; Nishihori, T; Ochoa-Bayona, JL; Perkins, J; Pidala, J; Roman-Diaz, J; Tate, C; Tomblyn, M | 1 |
| Basok, A; Mostoslavsky, M; Rogachev, B; Shnaider, A; Tovbin, D | 1 |
| Nicolle, A; Proctor, SJ; Summerfield, GP | 1 |
| Au, WY; Ho, SL; Kwong, YL; Leung, SY; Mak, W | 1 |
| Bontemps, F; Cardoen, S; Offner, F; Van den Neste, E | 1 |
| Kneba, M; Moosig, F; Schoch, R | 1 |
| Aribi, A; Faderl, S; Ferrajoli, A; Huh, Y; Kantarjian, H; Keating, M; O'brien, S; Ravandi, F; Wierda, W | 1 |
| Bell, DE; Dow, LW; Fridland, A; Poulakos, L | 1 |
| Alexander, L; Chubb, S; Montgomery, JA; Plunkett, W | 1 |
| Aleskog, A; Höglund, M; Kristensen, J; Larsson, R; Sundström, C | 1 |
| Blanche, P; Bouscary, D; Dreyfus, F; Gombert, B; Sicard, D; Stieltjes, N | 1 |
| Itälä, M; Remes, K | 1 |
3 review(s) available for fludarabine and Leukemia, Lymphoid
| Article | Year |
|---|---|
Old and new insights into the mechanisms of action of two nucleoside analogs active in lymphoid malignancies: fludarabine and cladribine (review).
Topics: Antineoplastic Agents; Apoptosis; Caspases; Cell Cycle; Cell Membrane; Cell Proliferation; Cell Survival; Cladribine; DNA; DNA Damage; DNA Repair; DNA-Directed DNA Polymerase; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Models, Biological; Models, Chemical; Nucleosides; RNA; Signal Transduction; Tumor Suppressor Protein p53; Vidarabine | 2005 |
[T-large granular lymphocyte leukaemia. An important differential diagnosis to Felty's syndrome].
Topics: Antirheumatic Agents; Antiviral Agents; Arthritis, Rheumatoid; Diagnosis, Differential; Felty Syndrome; Humans; Immunosuppressive Agents; Leukemia, Lymphoid; Leukemia, T-Cell; Methotrexate; Vidarabine | 2006 |
[Nucleoside analogues--new drugs for the treatment of lymphatic cancers].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Cladribine; Clinical Trials as Topic; Humans; Leukemia, Lymphoid; Lymphoma; Nucleosides; Pentostatin; Vidarabine | 2001 |
1 trial(s) available for fludarabine and Leukemia, Lymphoid
| Article | Year |
|---|---|
T-cell large granular lymphocytic (T-LGL) leukemia: experience in a single institution over 8 years.
Topics: Adult; Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Cyclosporine; Female; Flow Cytometry; Humans; Immunophenotyping; Leukemia, Lymphoid; Leukemia, T-Cell; Male; Middle Aged; Pentostatin; Retrospective Studies; Vidarabine | 2007 |
14 other study(ies) available for fludarabine and Leukemia, Lymphoid
| Article | Year |
|---|---|
Affecting NF-κB cell signaling pathway in chronic lymphocytic leukemia by dendrimers-based nanoparticles.
Topics: Cell Line, Tumor; Dendrimers; Gene Expression Regulation; Humans; Leukemia, Lymphoid; Nanoparticles; NF-kappa B; Protein Array Analysis; Signal Transduction; Transcriptome; Vidarabine | 2018 |
Late-onset Pneumocystis jirovecii pneumonia post-fludarabine, cyclophosphamide and rituximab: implications for prophylaxis.
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; Leukemia, Lymphoid; Lymphoma; Male; Middle Aged; Pneumocystis carinii; Pneumonia, Pneumocystis; Rituximab; Treatment Outcome; Vidarabine | 2013 |
Telomerase contributes to fludarabine resistance in primary human leukemic lymphocytes.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Catalytic Domain; Chromosome Deletion; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 17; DNA Helicases; Drug Resistance, Neoplasm; Enzyme Activation; Gene Expression Regulation, Leukemic; Histones; Humans; Indoles; Ku Autoantigen; Leukemia, Lymphoid; Middle Aged; Niacinamide; Oligonucleotides; Phosphorylation; Protein Binding; Telomerase; Vidarabine | 2013 |
The frequency, manifestations, and duration of prolonged cytopenias after first-line fludarabine combination chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Female; Hematologic Diseases; Humans; Leukemia, Lymphoid; Leukopenia; Male; Middle Aged; Neoadjuvant Therapy; Neutropenia; Pancytopenia; Prevalence; Retrospective Studies; Thrombocytopenia; Time Factors; Vidarabine | 2010 |
Assessment of peripheral blood and bone marrow cells apoptosis caused by purine analogues in patients with chronic lymphocytic leukemia in correlation with parameters of disease progression.
Topics: ADP-ribosyl Cyclase 1; Antineoplastic Agents; Apoptosis; B-Lymphocyte Subsets; bcl-2-Associated X Protein; Biomarkers; Bone Marrow Cells; Caspase 3; Chronic Disease; Cladribine; Disease Progression; Enzyme Activation; Humans; Leukemia, Lymphoid; Membrane Glycoproteins; Prognosis; Proto-Oncogene Proteins c-bcl-2; Tumor Cells, Cultured; Vidarabine; ZAP-70 Protein-Tyrosine Kinase | 2010 |
Rhodococcus equi pneumonia in a patient with fludarabine-treated chronic lymphocytic leukemia and CD4-lymphopenia.
Topics: Actinomycetales Infections; Aged, 80 and over; Anti-Bacterial Agents; Antineoplastic Agents; Bronchoalveolar Lavage Fluid; CD4 Lymphocyte Count; Chronic Disease; Female; Humans; Leukemia, Lymphoid; Lymphopenia; Opportunistic Infections; Pneumonia, Bacterial; Rhodococcus equi; Vidarabine | 2010 |
Targeted IV busulfan and fludarabine followed by post-allogeneic hematopoietic cell transplantation rituximab demonstrate encouraging activity in CD20+ lymphoid malignancies without increased risk of infectious complications.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Cohort Studies; Female; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Lymphoid; Lymphoma; Male; Middle Aged; Retrospective Studies; Rituximab; Transplantation Conditioning; Vidarabine | 2011 |
Severe hypoglycemia in a patient with acute renal failure due to tumor lysis syndrome.
Topics: Acute Kidney Injury; Antineoplastic Agents; Female; Humans; Hypoglycemia; Leukemia, Lymphoid; Middle Aged; Severity of Illness Index; Tumor Lysis Syndrome; Vidarabine | 2002 |
High dose chlorambucil in the treatment of lymphoid malignancies.
Topics: Antineoplastic Agents, Alkylating; Chlorambucil; Clinical Trials as Topic; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Lymphoma; Lymphoma, Non-Hodgkin; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Vidarabine | 2004 |
Reversible paraneoplastic neuropathy associated with T-cell large granular lymphocyte leukemia.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclosporine; Dexamethasone; Female; Humans; Immunosuppressive Agents; Leukemia, Lymphoid; Male; Middle Aged; Mitoxantrone; Nerve Degeneration; Paraneoplastic Polyneuropathy; Paresthesia; Sural Nerve; T-Lymphocytes; Urinary Retention; Vidarabine | 2004 |
Differences in metabolism and cytotoxicity between 9-beta-D arabinofuranosyladenine and 9-beta-D-arabinofuranosyl-2-fluoroadenine in human leukemic lymphoblasts.
Topics: Cell Survival; Cells, Cultured; Deoxycytidine; DNA, Neoplasm; Humans; Leukemia, Lymphoid; Phosphotransferases; Vidarabine | 1980 |
Comparison of the toxicity and metabolism of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine in human lymphoblastoid cells.
Topics: Adenosine Deaminase Inhibitors; Adenosine Triphosphate; Antineoplastic Agents; Cells, Cultured; Coformycin; DNA; Dose-Response Relationship, Drug; Humans; Leukemia, Lymphoid; T-Lymphocytes; Vidarabine | 1980 |
Evaluation of purine and pyrimidine analogues in human tumor cells from patients with low-grade lymphoproliferative disorders using the FMCA.
Topics: Acute Disease; Antineoplastic Agents; Cladribine; Cytarabine; Fluorescence; Fluorometry; Humans; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Survival Analysis; Vidarabine | 1999 |
Successful treatment of acquired factor VIII inhibitor with fludarabine and cyclophosphamide in chronic lymphoid leukemia.
Topics: Aged; Antibodies; Chronic Disease; Cyclophosphamide; Factor VIII; Female; Hemorrhage; Humans; Immunosuppressive Agents; Leukemia, Lymphoid; Vidarabine | 1999 |